Ergomar side effects by duration, gender and age - a phase IV clinical study of FDA data

female:

1. Drug hypersensitivity
2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
4. Blood creatine phosphokinase increased
5. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
6. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

1. Drug ineffective
2. Renal infarct (kidney damage due to lack of blood supply)

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

1. Blood creatine phosphokinase increased

40-49:

n/a

50-59:

1. Drug hypersensitivity
2. Renal infarct (kidney damage due to lack of blood supply)
3. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)

60+:

1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
2. Drug ineffective